Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03061916Phase 3Unknown
Phase 3, randomised, single-blind trial (3 arms), sponsored by Cairo University. Primary endpoint: Viability count of Mutans Streptococci in saliva at 2 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03061916.